FMP
NASDAQ
33.77 USD
0.91 (2.69%)
Mr. Joseph E. Payne M.Sc.
Healthcare
Biotechnology
https://arcturusrx.com
NASDAQ
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therap...
0001768224
US03969T1097
03969T109
10628 Science Center Drive
858 900 2660
US
180
May 22, 2013
0001768224
NASDAQ
Biotechnology
Healthcare
03969T109
US03969T1097
US
33.77
2.64
440.94k
908.93M
-
17.52-43.81
-28.32
-
-
-
-
-30.15
-
https://arcturusrx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.